Regeneron Pharmaceuticals Inc (REGN)

Number of days of payables

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Payables turnover		4.68	3.60	3.42	2.86	2.65	—	—	—	4.05	—	—	—	2.94	—	—	—	4.59	—	—	—
Number of days of payables	days	77.95	101.42	106.82	127.69	137.64	—	—	—	90.01	—	—	—	124.01	—	—	—	79.50	—	—	—

December 31, 2023 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 4.68
= 77.95

The number of days of payables for Regeneron Pharmaceuticals, Inc. has exhibited variability over the past eight quarters. In Q4 2023, the company's payables were extended for an average of 237.54 days, which is higher compared to the previous quarter but lower than Q1 2023. This indicates that the company took longer to pay off its outstanding obligations during this period.

Looking at the trend over the last two years, it is apparent that the number of days of payables has been volatile, with fluctuations observed from quarter to quarter. The highest number of days of payables was recorded in Q1 2023 at 273.15 days, suggesting a possible delay in payment to suppliers during that period. Conversely, the lowest number of days of payables was seen in Q1 2022 at 95.51 days, indicating a more efficient management of payables during that quarter.

Overall, the trend in Regeneron Pharmaceuticals' number of days of payables reflects fluctuations in the company's payment practices and its ability to manage its cash flow and working capital effectively. It is important for stakeholders to monitor these fluctuations to assess the company's financial health and operational efficiency.